Effect of Carbocisteine on Common Cold Morbidity in Asthma Patients
- Conditions
- Asthma
- Registration Number
- JPRN-UMIN000006234
- Lead Sponsor
- Dokkyo Medical University, Department of Pulmonary Medicine and Clinical Immunology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Not provided
1) patients intolerant to carbocisteine; 2) patients planned to take oral steroids, antibacterials/antibiotics, antitussives, or expectorants at the start of the study; 3) patients participating in another study at the start of the study; 4) patients who had started hyposensitization therapy or nonspecific therapy within 3 months or who planned on such therapy after the start of the study; 5) patients with comorbidities such as COPD or bronchiectasis; 6) patients with serious hepatic disease, renal disorders, heart disease, or other comorbidities; 7) patients with malignant tumors; 8) patients who were or may have been pregnant; 9) lactating patients; 10) patients determined unsuitable by an investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method